Here is a list of anti-seizure medication (ASM), previously called anti-epileptic drugs or AEDs, with links to information about what type of seizures they are used for, doses, and possible side ...

Lichen planus is believed to be an autoimmune disease, although its exact cause remains unknown. It’s thought that exposure to viruses, drugs, or allergens may alter skin cells, prompting an ...

Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials ...

And while there are many medications out there to help people cope with pain, they can often cause their own headaches, to say the very least. Now a pharmaceutical company is potentially on the ...

Here’s our process. If you’re managing a sexually transmitted infection (STI), you have options for treatment. While you can visit a healthcare professional in person for an evaluation and ...

A year ago, life for many people in the UK with attention deficit hyperactivity disorder (ADHD) became unpredictable and disorientating as their medications suddenly became scarce. They were told ...

The Central Drug Standards Control Organisation (CDSCO) has flagged more than 50 drugs for common conditions like high blood pressure and acid reflux as substandard. This includes batches from ...

India's drug regulator has identified 53 drugs, including supplements and medications for diabetes and high blood pressure, as 'Not of Standard Quality.' These drugs are produced by several ...

Lichen sclerosus (LS) is a chronic inflammatory condition predominantly affecting the ... Histopathological examination typically reveals subepithelial hyalinization, loss of elastic fibers, and a ...

Perry Kendall was a cofounder of Fair Price Pharma, a not-for-profit dedicated to providing low-cost Canadian access to diacetylmorphine morphine as a treatment option for individuals whose ...

(Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced an update on its ongoing ...